PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of General Medicine, Epworth Richmond Hospital, Richmond, Victoria, Australia.\', \'Department of General Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia.\', \'Department of Renal Medicine, Epworth Richmond Hospital, Richmond, Victoria, Australia.\', \'The University of Melbourne, Parkville, Victoria, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/nep.13767
?:doi
?:hasPublicationType
?:journal
  • Nephrology (Carlton, Vic.)
is ?:pmid of
?:pmid
?:pmid
  • 32776624
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Clinical benefits of Tocilizumab in COVID-19-related cytokine release syndrome in a patient with end-stage kidney disease on haemodialysis in Australia.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all